Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-09-23
Original SEC Filing: Click here

---

Webplus: SVA/20200923/6-K_1/2_EX-99.1/000.htm SEC Original: tm2031596d1_ex99-1.htm
Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it has recently commenced phase III clinical trials for its inactivated BEIJING, China, September 22, 2020 –(BUSINESS WIRE)– This case-driven, randomized, double-blinded and placebo-controlled phase III clinical trial

---

---

Webplus: SVA/20200923/6-K_1/1/000.htm SEC Original: tm2031596d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-09-23CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200